SELECTION SUMMARY
도입 판단 요약
Monthly Cumulative Percent of Children <8 Months Who Received 1+ Monoclonal Antibody by Jurisdiction, United States. RSV monoclonal antibody coverage for children 0 to 7 months is assessed through U.S. jurisdictions’ Immunization Information Systems Resources (IIS) data, submitted from jurisdictions to CDC monthly in aggregate by age group. Monthly estimates shown are cumulative, reflecting all children who received an RSV monoclonal antibody from April 1 through the end of the reporting month.*,† Cumulative estimates include any historical data reported since the previous submission. National estimates are not presented since not all U.S. jurisdictions are currently reporting their IIS data to CDC. Jurisdictions reporting data to CDC include U.S. states, some localities, and territories.
이 제품의 적합 용도와 제한 조건은 아직 검수하지 않았습니다. 태그와 카테고리는 찾아가는 길이지 적합성 보증이 아닙니다.